Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-13

FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved Palonosetron hydrochloride from Sandoz Inc via an Original Application (ANDA) for use in preventing chemotherapy- and postoperative-induced nausea …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

ORIG AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)